Occident Group
Entry last updated on January 9, 2025

OCCIDENT invests in deep-tech startups with a focus on spin-offs from scientific research, thus creating real impact and enabling concrete solutions to various societal challenges. As an owner-managed venture capital investor with offices in Munich and Zug, OCCIDENT supports startups in the life sciences and industrial tech sectors from the seed financing round onwards, provides long-term support to its portfolio companies both financially and with its extensive experience, and thus enables founding teams to achieve outstanding results.

With a strong entrepreneurial mindset, OCCIDENT invests its own capital and makes decisions based on their long-term potential for success. The collaboration with the founding teams of its portfolio companies inspires the OCCIDENT team every day. Their passion and drive inspire, and the often intense exchange motivates them to tackle challenges together. OCCIDENT's goal with each of its investments is to make a lasting, positive contribution to society.

Show English Description

Facts
 
Contact
 

2

Founders

2012

Founding year

Stage

Company location

OCCIDENT
Klenzestraße 22
80469 Munich

Last investment

Oct 2025

Dealroom Insights

Funding

Funding rounds

Date Investors Startup Amount Round
June 2023 Mayo Clinic, Panakès Partners, OCCIDENT, LIFT, EFI Lake Geneva Ventures, EIC FundEBAMed€14.35m SERIES A
July 2023 HTGF, Xista Science Ventures, OCCIDENTReCatalyst€1.7m SEED
January 2024 HTGF, OCCIDENTChipmetrics€2.4m SEED
February 2024 HTGF, TGFS, Tuesday, bm-t Investment Management Thuringia, OCCIDENT, Novalis Biotech, Saxonia Systems HoldingAltavo€5m SERIES A
February 2024 Hesse Capital, OCCIDENT, Poppe + Potthoff, BHS Corrugatedcore sensingN/A EARLY VC
March 2024 HTGF, Seventure Partners, BioMed Partners, EQT Life Sciences, Bavaria Capital, Coparion, Evotec, FundPlus, Andera Partners, Nextech Invest, OCCIDENT, Deep Track Capital, Frazier Life SciencesTubules€128m SERIES B
March 2024 ZKB - Zurich Cantonal Bank, Hemex, OCCIDENT, VP Venture Partners, EFI Lake Geneva Ventures, Belmondo Family Officehemotune₣14m SERIES B
Oct 2024 HTGF, CDP Venture Capital, ZKB - Zurich Cantonal Bank, Investors' club, Panakès Partners, TechWald Holding, OCCIDENTLymphatica Medtech€17.9m SERIES B
June 2025 HTGF, Seventure Partners, BioMed Partners, Bavaria Capital, EQT Ventures, Coparion, Evotec, Nextech, OCCIDENT, Deep Track Capital, Frazier Life Sciences, Fund+, Science Holding, HSM Holding, LeXito, ZweiKa Holding, Greendale Holding, South Lake HoldingTubulesN/A LATE VC
Oct 2025 HTGF, Seventure Partners, Venrock, Wellington Management, EQT Life Sciences, Bavaria Capital, Andera Partners, Nextech Invest, OCCIDENT, Deep Track Capital, Ascenta Capital, Frazier Life Sciences, Fund+Tubules€308m SERIES C

You might also be interested in

YFood

News

Nestlé secures Yfood

Anyone strolling through the supermarket can't miss Yfood anymore. Now there's a big change coming from the Munich-based startup…

Myriameate

7 Questions

Myriameat: Real meat without slaughter

Myriameat is developing a platform for producing genuine animal muscle tissue from stem cells – without animal husbandry or slaughter. The biotech startup has already cultivated…

News

Munich Startup Recap 23/26

When a million euros never arrives, even though you fully expect it, it's quite a disappointment and puts a stop to everything.